Oxford BioMedica Plc - Company Profile
Powered by 
All the data and insights you need on Oxford BioMedica Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Oxford BioMedica Plc Strategy Report
- Understand Oxford BioMedica Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Oxford BioMedica Plc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 14 Sep 2022 | Undisclosed Client Enters Manufacturing Agreement with Oxford Biomedica for gene therapy | Contract Service Agreement | - |
Oxford BioMedica Plc |
| 26 Jul 2022 | Oxford Biomedica Enters into Licensing Agreement for LentiVector Platform | Licensing Agreement | - |
Oxford BioMedica Plc |
| 26 Jul 2022 | Oxford Biomedica Enters into Licensing Agreement Gene Therapy Company | Licensing Agreement |
Oxford BioMedica Plc
|
- |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer